Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of this review is to assess its utility in the management of neutropenic patients. A delayed treatment of infection in this setting results in severe morbidity and high mortality. As traditional diagnostic tools often fail to exclude infection when fever occurs, all these patients receive empirical antimicrobial therapies during long periods of time. Present knowledge suggests that procalcitonin may contribute to identify patients in whom 1) antibiotics could be stopped in the absence of bacterial infection, 2) investigations and adjustments of the antimicrobial therapy for persistent fever are needed. The use of procalcitonin for the management o...
Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection. Proca...
In contrast to Calcitonin that is primarily synthesized in the thyroid, Procalcitonin is the prohorm...
Procalcitonin (PCT) is a biomarker that is increasingly being used to help in decision making when m...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
In order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutropenia from...
ABSTRACTIn order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutrope...
The novel inflammatory marker procalcitonin (PCT) was assessed as an index of infection in patients ...
Patients with neutropenia are exposed to a high risk for infections in which fever is often the uniq...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
An ideal marker for bacterial infections should allow an early diagnosis, inform about the course an...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
This review describes the pathophysiological basis for using procalcitonin to help diagnose infectio...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
In oncologic patients fever is a non-specific clinical marker of different clinical settings. Procal...
Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection. Proca...
In contrast to Calcitonin that is primarily synthesized in the thyroid, Procalcitonin is the prohorm...
Procalcitonin (PCT) is a biomarker that is increasingly being used to help in decision making when m...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
In order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutropenia from...
ABSTRACTIn order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutrope...
The novel inflammatory marker procalcitonin (PCT) was assessed as an index of infection in patients ...
Patients with neutropenia are exposed to a high risk for infections in which fever is often the uniq...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
An ideal marker for bacterial infections should allow an early diagnosis, inform about the course an...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
This review describes the pathophysiological basis for using procalcitonin to help diagnose infectio...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
In oncologic patients fever is a non-specific clinical marker of different clinical settings. Procal...
Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection. Proca...
In contrast to Calcitonin that is primarily synthesized in the thyroid, Procalcitonin is the prohorm...
Procalcitonin (PCT) is a biomarker that is increasingly being used to help in decision making when m...